Hatem Shehata

814 total citations
35 papers, 361 citations indexed

About

Hatem Shehata is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Hatem Shehata has authored 35 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 18 papers in Neurology and 6 papers in Neurology. Recurrent topics in Hatem Shehata's work include Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (6 papers) and Migraine and Headache Studies (5 papers). Hatem Shehata is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (6 papers) and Migraine and Headache Studies (5 papers). Hatem Shehata collaborates with scholars based in Egypt, United Kingdom and Saudi Arabia. Hatem Shehata's co-authors include Nevin Shalaby, Alaa Elmazny, Amr Hassan, Ahmed Abdelalim, Nirmeen A. Kishk, Maged Abdel Naseer, Mohamed Hegazy, Shaimaa I El-Jaafary, Sherif Hamdy and Rehab Magdy and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Journal of the Neurological Sciences.

In The Last Decade

Hatem Shehata

31 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hatem Shehata Egypt 11 220 149 120 76 60 35 361
Fernando Monsalve Iglesias Spain 9 158 0.7× 131 0.9× 180 1.5× 65 0.9× 17 0.3× 22 374
Alaa Elmazny Egypt 11 128 0.6× 79 0.5× 88 0.7× 34 0.4× 55 0.9× 33 304
Silvia Messina Italy 11 190 0.9× 100 0.7× 36 0.3× 18 0.2× 28 0.5× 15 301
Jannis Müller Switzerland 8 159 0.7× 58 0.4× 109 0.9× 23 0.3× 48 0.8× 21 275
Alessandro Clemenzi Italy 9 165 0.8× 115 0.8× 54 0.5× 36 0.5× 26 0.4× 13 285
Maged Abdel Naseer Egypt 11 84 0.4× 45 0.3× 36 0.3× 34 0.4× 72 1.2× 28 282
Nadia Tenenbaum United States 11 234 1.1× 90 0.6× 122 1.0× 42 0.6× 26 0.4× 21 369
Mario Falcini Italy 10 318 1.4× 199 1.3× 48 0.4× 34 0.4× 66 1.1× 13 428
Maria Buccafusca Italy 10 216 1.0× 197 1.3× 29 0.2× 21 0.3× 56 0.9× 18 350
Lou Grangeon France 12 76 0.3× 147 1.0× 177 1.5× 87 1.1× 32 0.5× 33 367

Countries citing papers authored by Hatem Shehata

Since Specialization
Citations

This map shows the geographic impact of Hatem Shehata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatem Shehata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatem Shehata more than expected).

Fields of papers citing papers by Hatem Shehata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatem Shehata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatem Shehata. The network helps show where Hatem Shehata may publish in the future.

Co-authorship network of co-authors of Hatem Shehata

This figure shows the co-authorship network connecting the top 25 collaborators of Hatem Shehata. A scholar is included among the top collaborators of Hatem Shehata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatem Shehata. Hatem Shehata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shehata, Hatem, Hanan S. El‐Abhar, Dalaal M. Abdallah, & Ayman A. Soubh. (2025). From liver to kidney: Telmisartan attenuates NLRP3 inflammasome-driven systemic inflammation and the iNOS/Hsp70 axis partially via the Mas receptor in a hepatic ischemia-reperfusion model. European Journal of Pharmacology. 1005. 178098–178098.
3.
Shalaby, Nevin, et al.. (2025). Efficacy of ocrelizumab versus rituximab in patients with relapsing-remitting multiple sclerosis. Acta Neurologica Belgica. 125(4). 999–1006. 1 indexed citations
4.
Kishk, Nirmeen A., Reham Shamloul, Rehab Magdy, et al.. (2024). Epilepsy Arabic renaming to cerebroelectric disorder could minimize the stigma. Epilepsy Research. 210. 107495–107495.
5.
6.
Naseer, Maged Abdel, et al.. (2024). Prevalence of primary headaches in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 86. 105602–105602. 2 indexed citations
7.
Shehata, Hatem, Sherif Hamdy, Maged Abdel Naseer, et al.. (2024). Effect of high frequency repetitive transcranial magnetic stimulation (rTMS) on the balance and the white matter integrity in patients with relapsing-remitting multiple sclerosis: A long-term follow-up study. Multiple Sclerosis and Related Disorders. 83. 105471–105471. 5 indexed citations
8.
9.
Shehata, Hatem, et al.. (2023). Predictors of severity and outcome of multiple sclerosis relapses. BMC Neurology. 23(1). 67–67. 8 indexed citations
10.
Kishk, Nirmeen A., Nevin Shalaby, Hatem Shehata, et al.. (2021). The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt. BMC Neurology. 21(1). 53–53. 3 indexed citations
11.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach</p>. Therapeutics and Clinical Risk Management. Volume 16. 651–662. 11 indexed citations
12.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era</p>. Therapeutics and Clinical Risk Management. Volume 16. 759–767. 3 indexed citations
13.
Kishk, Nirmeen A., et al.. (2019). <p>Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2571–2578. 10 indexed citations
14.
Shehata, Hatem, et al.. (2017). Development and validation of an Arabic-language headache questionnaire for population-based surveys. Journal of Pain Research. Volume 10. 1289–1295. 10 indexed citations
15.
Gad, Adel, et al.. (2016). Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients. Journal of the Neurological Sciences. 369. 36–38. 8 indexed citations
16.
Shehata, Hatem, et al.. (2016). Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial. Journal of Pain Research. Volume 9. 771–777. 34 indexed citations
17.
Shehata, Hatem, et al.. (2015). Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients. Neurological Sciences. 36(9). 1651–1657. 17 indexed citations
18.
Shalaby, Nevin, et al.. (2015). Prevalence of primary headache disorders in Fayoum Governorate, Egypt. The Journal of Headache and Pain. 16(1). 85–85. 28 indexed citations
19.
Shehata, Hatem, et al.. (2014). Oromandibular dystonia in Yemeni patients with khat chewing: a response to botulinum toxin treatment. Neurology International. 6(2). 5385–5385. 7 indexed citations
20.
Shehata, Hatem, et al.. (2013). Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?. The Journal of Headache and Pain. 14(1). 92–92. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Monsalve Iglesias Breakdown of academic impact, for papers by Alaa Elmazny Breakdown of academic impact, for papers by Silvia Messina Breakdown of academic impact, for papers by Jannis Müller Breakdown of academic impact, for papers by Alessandro Clemenzi Breakdown of academic impact, for papers by Maged Abdel Naseer Breakdown of academic impact, for papers by Nadia Tenenbaum Breakdown of academic impact, for papers by Mario Falcini Breakdown of academic impact, for papers by Maria Buccafusca Breakdown of academic impact, for papers by Lou Grangeon
Rankless by CCL
2026